002622 Whole Shine Medical Technology
- 1.53
- +0.08+5.52%
Whole Shine Medical Technology News
Express News | Hao Chen Healthcare: The largest shareholder changed to SPD Bank Guangzhou Branch
Hao Chen Medical (002622.SZ): Net loss of 4.57 million yuan in the first quarter increased year-on-year loss
On April 28, Ge Longhui | Hao Chen Medical (002622.SZ) released its first quarter report. Operating income was 160 million yuan, up 26.12% year on year, net loss was 4.57 million yuan, increasing year-on-year loss, after deducting non-net loss of 4.699 million yuan. The year-on-year loss increased, with basic earnings per share -0.0054 yuan.
Hao Chen Medical (002622.SZ): Pre-loss of 90 million yuan to 170 million yuan in 2023
Ge Longhui, January 30 | Haochen Medical (002622.SZ) announced the 2023 annual results forecast, with operating income of 70,000,000 yuan to 78,0000 million yuan for the reporting period; net profit loss attributable to shareholders of listed companies of 170.01 million yuan to 90 million yuan, loss of 256.787 million yuan for the same period last year; net profit loss after deducting non-recurring profit and loss of 14,500,000 yuan - 75.0 million yuan, loss of 915.25 million yuan for the same period last year; basic earnings loss per share 0.2024 yuan/share — 0.1
Haochen Healthcare (002622.SZ): Unable to get in touch with director Zhu Gujia
Gelonghui on December 7 | Haochen Healthcare (002622.SZ) announced that the company learned through an announcement disclosed by Shenzhen Yushun Electronics Co., Ltd. on December 6, 2023, that it was unable to get in touch with Ms. Zhu Gujia, chairman of its board of supervisors. The company was also unable to get in touch with Ms. Zhu Gujia through phone calls, WeChat, etc. Up to now, the company is not sure the specific reason for not being able to get in touch with Ms. Zhu Gujia. With the exception of being a director of the company and a member of the strategy committee of the board of directors, Ms. Zhu Gujia has not held any other position in the company.
Haochen Healthcare: Unable to get in touch with the director
Gelonghui, December 6 | Haochen Medical Announcement. The company learned through an announcement disclosed by Shenzhen Yushun Electronics Co., Ltd. on December 6, 2023, that it was unable to get in touch with Ms. Zhu Gujia, chairman of its board of supervisors. The company was also unable to get in touch with Ms. Zhu Gujia through phone calls, WeChat, etc. Up to now, the company is not sure the specific reason for not being able to get in touch with Ms. Zhu Gujia. With the exception of being a director of the company and a member of the strategy committee of the board of directors, Ms. Zhu Gujia has not held any other position in the company. As of the disclosure date of the announcement, Ms. Zhu Gujia did not hold any shares in the company.
[BT Financial Report Instantaneous Analysis] Haochen Medical's 2023 Three-Quarter Report Reveals: Steady Growth in Performance, Dual Business Strategy Shows Results
Haochen Medical Technology Co., Ltd. (stock code: 002622), as a dual-track enterprise in the field of dental medical services and electrical equipment manufacturing, shows the steady development trend of the company under the “dental medical service+industrial manufacturing” business model for the third quarter of 2023. As the company's dental care service brand, Derun Medical enjoys high brand influence in Guangzhou and Foshan, while in the electrical industry, the company has demonstrated its competitive advantage by continuously developing new products and developing new markets. In terms of assets and liabilities, Haochen Healthcare's total assets increased from 16.3 at the end of the previous year
[Instant Analysis of BT Financial Report] Hao Chen Medical's 2023 Interim Report: Business has gradually improved, and revenue and net profit have increased significantly
Hao Chen Medical Technology Co., Ltd. (stock code: 002622) is a company mainly engaged in dental care services and the development, production and sales of complete equipment products for permanent magnet switches and high and low voltage switches. The company has formed an industrial pattern with the dual main business of “dental medical services+industrial manufacturing”. In the dental care service industry, the company focuses on the diagnosis and treatment of oral diseases, oral health care and restoration services, and has established dental care service chains in Guangzhou and Foshan, and has strong regional brand influence. In the electrical industry, the company's permanent magnet switch business belongs to the electrical manufacturing industry.
Haochen Healthcare (002622.SZ) made a profit and expects net profit of 6.6 million yuan to 9.6 million yuan in the first half of the year to turn a year-on-year loss into a profit
According to the Zhitong Finance App, Haochen Healthcare (002622.SZ) released its 2023 semi-annual results forecast. Net profit attributable to shareholders of listed companies in the first half of the year is 6.6 million yuan to 9.6 million yuan, turning a loss into a profit over the previous year. During the reporting period, market demand in the dental medical services and traditional permanent magnet switch industries in which the company is located picked up. The company seized the opportunity to actively explore the market while continuing to promote cost reduction and efficiency. The company's dental medical service business and traditional permanent magnet switch business both achieved steady growth in revenue, and overall operating performance improved significantly over the same period last year.
Some bank accounts of Haochen Healthcare (002622.SZ) and its subsidiaries have been blocked
According to the Zhitong Finance App, Haochen Medical (002622.SZ) issued an announcement. The company recently learned that some bank accounts of the company and its subsidiaries Jilin Yongda Electric Switch Co., Ltd. (hereinafter referred to as “Yongda Electric”) and Rongyu Huatong Leasing (Tianjin) Co., Ltd. (hereinafter referred to as “Rongyu Huatong”) have been frozen and that some of the company's bank accounts have been unfrozen. The company learned through an inquiry on the China Enforcement Information Disclosure Network that the Beijing No. 1 Intermediate People's Court has filed a case against the company. Case number: (2023), Beijing 01 issued 847, execution target: 135 million yuan. Currently, the company has not received a letter from the court
Haochen Healthcare (002622.SZ): Control may change
On July 4, 2023, GLONGHUI | Haochen Healthcare (002622.SZ) announced that on July 4, 2023, the company received a notice from Huiyin Rifeng. As of now, Beijing Shoutuo Ronghui has not paid priority trust beneficiary transfers to the Guangzhou branch of SPD Bank. Based on this, according to the agreement of the cooperation agreement, in principle, the cooperation agreement between Beijing Shoutuo Ronghui and Huiyin Aofeng has already triggered a termination clause, and there is a possibility that the company's control will change. Currently, all parties involved are still actively communicating, and there is still great uncertainty about whether the company's control will eventually change and the exact time of the change.
Hao Chen Medical (002622.SZ) released its first quarter results, with a net loss of 7071,000 yuan, a narrowing of 97.21%
According to the Zhitong Finance App, Haochen Medical (002622.SZ) released a report for the first quarter of 2023. The company's revenue was 130 million yuan, an increase of 57.17% over the previous year. The net loss attributable to shareholders of listed companies was 7071,000 yuan, a year-on-year decrease of 97.21%. Net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,092,200 yuan, a year-on-year decrease of 95.71%. The basic loss per share was $0.0008.
Express News | Hao Chen Medical: Delun Dental has reported the amount of implants purchased by various brands in 2023 to the Guangdong Provincial Health Insurance Administration
Rongyu Group (002622.SZ), the new abbreviation “Hao Chen Medical”, was launched on December 13
According to the Zhitong Finance App, Rongyu Group (002622.SZ) announced that the company completed registration procedures for relevant industrial and commercial changes on December 12, 2022, and obtained the “Business License” issued by the Jilin Municipal Market Supervision Administration. The full Chinese name of the company was changed from “Rongyu Group Co., Ltd.” to “Haochen Medical Technology Co., Ltd.”; the English name of the company was “RONGYU GROUP CO., Ltd.” , LTD.” changed to “WALE SHINE MEDICAL TECHNOLOGY CO. , LTD.”; Company stock abbreviation
Express News | Rongyu Group: The company's stock abbreviation was changed to “Haochen Medical” on December 13
Rongyu Group (002622.SZ) plans to change its name to Haochen Medical Technology.
Zhitong Financial and Economic APP News, Rongyu Group (002622.SZ) issued an announcement that the company held the 19th interim meeting of the fifth board of directors on November 7, 2022, examined and passed the "proposal to change the company name, securities acronym and business scope", and agreed to change the company name to Haochen Medical Technology Co., Ltd., securities referred to as Haochen Medical Co., Ltd.
Express News | Rongyu Group: the abbreviation of the securities will be changed to "Haochen Medical treatment".
Rongyu Group (002622.SZ) released results for the first three quarters, with a net loss of 134.997 million yuan
According to the Zhitong Finance App, Rongyu Group (002622.SZ) released its report for the first three quarters of 2022, achieving revenue of 411 million yuan, an increase of 437.91% over the previous year. The net loss attributable to shareholders of listed companies was $13.4997 million. Net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was $149.316 million. Basic earnings per share - 0.0161 yuan/share.
Rongyu Group’s Actual Controller to Buy $91 Million More Shares
01:30 AM EDT, 10/12/2022 (MT Newswires) -- An entity owned by Rongyu Group's (SHE:002622) actual controller is buying another 652 million yuan ($91 million) worth of shares in the company. The Chinese
Express News | Rongyu Group: plan to raise no more than 652 million yuan
Rongyu Group (002622.SZ) plans to raise no more than 652 million yuan from enterprises controlled by real controllers. The issue price is 3.26 yuan per share.
Zhitong Financial APP News, Rongyu Group (002622.SZ) disclosed the 2022 non-public offering of A-share pre-plan, the object of this issue is Changzhou Yanyi Yongle Enterprise Management Center (limited partnership) ("Yanyi Yongle"). The issue price of the non-public offering shares is 3.26 yuan per share, the number of shares issued is not more than 200 million shares, and the total amount of funds to be raised is not more than 652 million yuan (including). After deducting the issuance expenses, the net funds raised will be used to supplement current funds and repay interest-bearing loans. Prior to this issue, Beijing Shoutuo Financial Investment Co., Ltd. ("Shoutuo Financial Exchange") passed the company's largest shareholder Guang.
Analysis
Price Target
No Data
